Funding for this research was provided by:
Canadian Institutes of Health Research (PJT-162314)
Canadian Cancer Society (703948)
Received: 7 March 2021
Accepted: 7 August 2021
First Online: 16 September 2021
: This study is approved by the University Health Network Research Ethics Board (#15-8942). All participants provided informed consent to participate in the prospective study as per institutional research ethics board stipulations (Clinicaltrials.gov: NCT03271892).
: There are no patient identifiers in the manuscript text or the images provided and therefore does not require consent of patients for publication.
: Dr. Sawka and Dr. Goldstein are Co-PIs in the ongoing prospective observation study ‘Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer (AS-PTC).’ The authors otherwise have no competing interest.